2010
DOI: 10.1136/bjo.2010.190942
|View full text |Cite
|
Sign up to set email alerts
|

Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 13 publications
0
9
0
Order By: Relevance
“…Measuring changes in metamorphopsia has been shown to be an effective method of detecting the condition 7,8 and of monitoring response to treatment. 14,15 D-charts offer some advantages over existing methods of measuring metamorphopsia. M-charts use smaller elements in the targets, which makes them difficult to use for patients with vision less than 0.6 logMAR.…”
Section: Discussionmentioning
confidence: 99%
“…Measuring changes in metamorphopsia has been shown to be an effective method of detecting the condition 7,8 and of monitoring response to treatment. 14,15 D-charts offer some advantages over existing methods of measuring metamorphopsia. M-charts use smaller elements in the targets, which makes them difficult to use for patients with vision less than 0.6 logMAR.…”
Section: Discussionmentioning
confidence: 99%
“…It has an 85% sensitivity rate and 85% specificity [7,8,9,10,11,12,13,14,15,16,17,18]. It is significantly more sensitive than the Amsler grid for early detection of CNV and shows changes after anti-VEGF therapy.…”
Section: Figmentioning
confidence: 99%
“…This mechanism allows for the creation of a quantified visual field map of the metamorphopsia for each eye and longitudinal detections of changes in such maps as well as deviation from the normal population [19]. For severity measurements we used the ‘PHP test score' [13]. This score is normalized to values of p between 0 and 1 (which indicates the probability of the tested eyes to have such a visual field defect) and has been previously validated as a classifier to discriminate between patients with intermediate non-neovascular AMD and patients with neovascular AMD.…”
Section: Methodsmentioning
confidence: 99%
“…However, these charts do not yield quantitative data. Preferential hyperacuity perimetry (PHP; ForeseeHome; Notal Vision, Tel Aviv, Israel) has recently gained popularity as a device for objectively monitoring visual distortion in age-related macular degeneration (AMD) [13,14]. …”
Section: Introductionmentioning
confidence: 99%